P3 Health Partners [PIII] vs Ardent Health [ARDT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: P3 Health Partners wins in 6 metrics, Ardent Health wins in 10 metrics, with 0 ties. Ardent Health appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricP3 Health PartnersArdent HealthBetter
P/E Ratio (TTM)-0.187.42P3 Health Partners
Price-to-Book Ratio0.641.60P3 Health Partners
Debt-to-Equity Ratio221.06138.17Ardent Health
PEG Ratio0.000.10P3 Health Partners
EV/EBITDA-0.987.08P3 Health Partners
Profit Margin (TTM)-9.99%4.11%Ardent Health
Operating Margin (TTM)-9.59%8.34%Ardent Health
EBITDA Margin (TTM)N/A8.34%N/A
Return on Equity-141.55%24.32%Ardent Health
Return on Assets (TTM)-24.31%5.61%Ardent Health
Free Cash Flow (TTM)$-110.13M$127.52MArdent Health
1-Year Return-54.23%-22.07%Ardent Health
Price-to-Sales Ratio (TTM)1.200.32Ardent Health
Enterprise Value$225.13M$4.12BArdent Health
EV/Revenue Ratio0.150.67P3 Health Partners
Gross Profit Margin (TTM)N/A83.55%N/A
Revenue per Share (TTM)$449$44P3 Health Partners
Earnings per Share (Diluted)$-51.33$1.89Ardent Health
Beta (Stock Volatility)0.84N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

P3 Health Partners vs Ardent Health Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
P3 Health Partners1.76%-11.37%1.41%35.58%-0.57%-30.80%
Ardent Health6.29%5.73%9.62%4.71%9.62%-16.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
P3 Health Partners-54.23%-96.42%-98.23%-98.23%-98.23%-98.23%
Ardent Health-22.07%-18.96%-18.96%-18.96%-18.96%-18.96%

News Based Sentiment: P3 Health Partners vs Ardent Health

P3 Health Partners

News based Sentiment: MIXED

September presented a mixed bag for P3 Health Partners, with positive analyst ratings and a brief stock rally offset by institutional selling and a projected revenue decline. The company is actively engaging with investors, but significant financial challenges remain, creating a high-risk, high-reward investment scenario.

View P3 Health Partners News Sentiment Analysis

Ardent Health

News based Sentiment: MIXED

Ardent Health experienced a slight stock decline in October, but also showed significant improvement in its Return on Capital Employed (ROCE) and appointed a new COO. These mixed signals create a balanced investment narrative, suggesting both potential and risk.

View Ardent Health News Sentiment Analysis

Performance & Financial Health Analysis: P3 Health Partners vs Ardent Health

MetricPIIIARDT
Market Information
Market Cap i$1.76B$2.01B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i6,590336,040
90 Day Avg. Volume i8,277381,800
Last Close$8.65$14.02
52 Week Range$5.80 - $26.00$10.10 - $20.72
% from 52W High-66.73%-32.34%
All-Time High$16.73 (Dec 06, 2021)$20.72 (Oct 14, 2024)
% from All-Time High-48.30%-32.34%
Growth Metrics
Quarterly Revenue Growth-0.06%0.12%
Quarterly Earnings Growth-0.06%0.71%
Financial Health
Profit Margin (TTM) i-0.10%0.04%
Operating Margin (TTM) i-0.10%0.08%
Return on Equity (TTM) i-1.42%0.24%
Debt to Equity (MRQ) i221.06138.17
Cash & Liquidity
Book Value per Share (MRQ)$13.60$8.77
Cash per Share (MRQ)$11.81$3.83
Operating Cash Flow (TTM) i$-129,955,000$301.98M
Levered Free Cash Flow (TTM) i$-1,812,750$19.78M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: P3 Health Partners vs Ardent Health

MetricPIIIARDT
Price Ratios
P/E Ratio (TTM) i-0.187.42
Forward P/E i-41.197.01
PEG Ratio i0.000.10
Price to Sales (TTM) i1.200.32
Price to Book (MRQ) i0.641.60
Market Capitalization
Market Capitalization i$1.76B$2.01B
Enterprise Value i$225.13M$4.12B
Enterprise Value Metrics
Enterprise to Revenue i0.150.67
Enterprise to EBITDA i-0.987.08
Risk & Other Metrics
Beta i0.84N/A
Book Value per Share (MRQ) i$13.60$8.77

Financial Statements Comparison: P3 Health Partners vs Ardent Health

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PIIIARDT
Revenue/Sales i$373.23M$1.50B
Cost of Goods Sold iN/A$258.86M
Gross Profit iN/A$1.24B
Research & Development iN/AN/A
Operating Income (EBIT) i$-38.09M$67.09M
EBITDA i$-16.72M$124.58M
Pre-Tax Income i$-43.17M$74.20M
Income Tax i$1.07M$15.23M
Net Income (Profit) i$-44.25M$58.97M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PIIIARDT
Cash & Equivalents i$40.08M$495.04M
Total Current Assets i$191.44M$1.76B
Total Current Liabilities i$507.03M$830.14M
Long-Term Debt i$117.10M$2.26B
Total Shareholders Equity i$121.08M$1.56B
Retained Earnings i$-523.67M$407.18M
Property, Plant & Equipment i$1.08M$2.06B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PIIIARDT
Operating Cash Flow i$-43.46M$21.34M
Capital Expenditures iN/A$-22.91M
Free Cash Flow i$-33.47M$-47.70M
Debt Repayment i$-341,000$-1.39M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPIIIARDT
Shares Short i23,9092.04M
Short Ratio i3.387.09
Short % of Float i0.07%0.06%
Average Daily Volume (10 Day) i6,590336,040
Average Daily Volume (90 Day) i8,277381,800
Shares Outstanding i3.26M142.75M
Float Shares i1.23M33.80M
% Held by Insiders i0.62%0.23%
% Held by Institutions i0.11%0.74%

Dividend Analysis & Yield Comparison: P3 Health Partners vs Ardent Health

MetricPIIIARDT
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A